Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Contact Information
Mesothelioma is a rare variety of cancer that most often affects people who have worked closely with asbestos materials, or otherwise sustained exposure to asbestos particulate. It affects a particular membrane that protects and covers the lungs and lines the inner chest cavity, called the pleura. There are many doctors who have made the treatment of mesothelioma patients a major part of their practice. One of these is Dr. Lary A. Robinson, who has offices in Tampa, Florida.
Dr. Robinson specializes in surgical mesothelioma treatment and therapy. He is Director of the Division of Cardiovascular and Thoracic Surgery at the H. Lee Moffitt Cancer Center and Research Institute. He also serves as a Professor of Surgery at the College of Medicine, University of South Florida. Dr. Robinson's interests in research focus on aggressive surgical treatment and therapy for those suffering from mesothelioma. He also sub-specializes in surgical critical care.
After receiving his medical degree from Washington University School of Medicine in St. Louis, Dr. Robinson interned at Duke University Medical Center, from 1972 to 1974, in general and thoracic surgery. Following that, he was a flight surgeon for the United States Air Force until 1976. In 1977, he was a surgery research fellow at Duke University Medical Center and in 1981 completed his residency there in general and thoracic surgery. He then proceeded to St. Thomas' Hospital in London for a cardiology fellowship, followed by a cardiac surgery fellowship at Duke University Medical Center.
Dr. Robinson is widely published, with well over 120 papers he has either authored or co-authored, including topics such as “Localized Pleural Mesothelioma: the Clinical Spectrum,” “Management of Pleural and Pericardial Effusions,” “Postoperative Complications of Pneumonectomy,” “The Pleural Tent: Radiographic Appearance,” “Locally Advanced Lung Cancer: Controversies in Management,” and “Intrapleural Doxycycline Control of Malignant Pleural Effusions.” He has also provided requested commentaries on numerous other papers.
Board-certified in surgical critical care, Dr. Robinson is also a Diplomat of the American Board of Surgery as well as the American Board of Thoracic Surgery. He serves on eight clinical cancer research programs and the Mesothelioma Applied Research Foundation's science advisory board.
During his career, which spans almost four decades, Dr. Robinson has been an Associate Professor of Surgery and Pharmacology at the University of Nebraska Medical Center, as well as the Clinical Director of the Clinical Perfusion Science Education Program. He has also been the principle thoracic surgical oncologist at the H. Lee Moffitt Cancer Center and Research Institute as well as a Professor of Surgery at the University of South Florida's College of Medicine.